Retinitis Pigmentosa: Practicalities, Patient Workup, and the Promise of...

Mark Pennesi, MD, PhD

Division Chief, Ophthalmic Genetics

Professor of Ophthalmology, School of Medicine

Oregon Health and Science University

Portland, OR

5:45 AM

Registration and Breakfast

6:00 AM

Introduction and Pretest

6:05 AM

Retinitis Pigmentosa: A Group of Rare Eye Diseases

6:20 AM

RP Workup: Practicalities, Genetic Testing, and Referral

6:40 AM

Delivery Scheduled! New Evidence on Gene Therapy for XLRP

7:00 AM

Panel Discussion: Prepping for the Use of RP Gene Therapy

7:15 AM

Posttest and Question & Answer

7:30 AM

Conclusion

Upon successful completion of this activity, participants should be better able to:

• Review the broad spectrum of genetic and phenotypic heterogeneity associated with retinitis pigmentosa.
• Evaluate objective and subjective assessment tools that may improve the workup of individuals suspected to have retinitis pigmentosa.
• Recognize the need for genetic counseling and testing, as well as prompt referral to a specialized clinic, to improve outcomes in patients with inherited retinal diseases.
• Assess new evidence about the use of gene therapy in the treatment of patients with X-linked retinitis pigmentosa.

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinitis pigmentosa.

This continuing medical education activity is provided by Vindico Medical Education.

This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Global Services, LLC.

This program is not affiliated with ASRS.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn Continuing Certification credits equivalent to the amount of CME credits claimed for the activity.

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

Faculty, topics, program schedule, and credit hours are subject to change. Recording of any manner is prohibited without written permission from Vindico Medical Education, Office of Medical Affairs and Compliance.

Event Venue & Nearby Stays

North Javits Center, 455 11th Avenue at 38th Street, New York, United States